Nuo Therapeutics Statistics
Total Valuation
Nuo Therapeutics has a market cap or net worth of 71.75 million. The enterprise value is 71.24 million.
| Market Cap | 71.75M |
| Enterprise Value | 71.24M |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nuo Therapeutics has 46.82 million shares outstanding. The number of shares has increased by 5.69% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 46.82M |
| Shares Change (YoY) | +5.69% |
| Shares Change (QoQ) | +2.14% |
| Owned by Insiders (%) | 47.48% |
| Owned by Institutions (%) | 2.20% |
| Float | 19.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.12 |
| PB Ratio | 80.21 |
| P/TBV Ratio | 80.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -28.72 |
| EV / Sales | 61.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -27.75 |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.88 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -2,362.58 |
Financial Efficiency
Return on equity (ROE) is -306.74% and return on invested capital (ROIC) is -149.61%.
| Return on Equity (ROE) | -306.74% |
| Return on Assets (ROA) | -93.43% |
| Return on Capital (ROIC) | -149.61% |
| Revenue Per Employee | 129,702 |
| Profits Per Employee | -275,577 |
| Employee Count | 9 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 1.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +239.05% in the last 52 weeks. The beta is -773.47, so Nuo Therapeutics's price volatility has been lower than the market average.
| Beta (5Y) | -773.47 |
| 52-Week Price Change | +239.05% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 67.73 |
| Average Volume (20 Days) | 3,043 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.22 |
Income Statement
In the last 12 months, Nuo Therapeutics had revenue of 1.17 million and -2.48 million in losses. Loss per share was -0.06.
| Revenue | 1.17M |
| Gross Profit | 909,518 |
| Operating Income | -2.48M |
| Pretax Income | -2.48M |
| Net Income | -2.48M |
| EBITDA | -2.47M |
| EBIT | -2.48M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 683,836 in cash and 179,308 in debt, giving a net cash position of 504,528 or 0.01 per share.
| Cash & Cash Equivalents | 683,836 |
| Total Debt | 179,308 |
| Net Cash | 504,528 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 890,387 |
| Book Value Per Share | 0.02 |
| Working Capital | 628,734 |
Cash Flow
In the last 12 months, operating cash flow was -2.41 million and capital expenditures -154,962, giving a free cash flow of -2.57 million.
| Operating Cash Flow | -2.41M |
| Capital Expenditures | -154,962 |
| Free Cash Flow | -2.57M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 77.92%, with operating and profit margins of -212.51% and -212.47%.
| Gross Margin | 77.92% |
| Operating Margin | -212.51% |
| Pretax Margin | -212.47% |
| Profit Margin | -212.47% |
| EBITDA Margin | -211.21% |
| EBIT Margin | -212.51% |
| FCF Margin | n/a |
Dividends & Yields
Nuo Therapeutics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.69% |
| Shareholder Yield | -5.69% |
| Earnings Yield | -3.66% |
| FCF Yield | -3.58% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nuo Therapeutics has an Altman Z-Score of -10.15. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.15 |
| Piotroski F-Score | n/a |